BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28603285)

  • 1. miR-511 promotes the proliferation of human hepatoma cells by targeting the 3'UTR of B cell translocation gene 1 (BTG1) mRNA.
    Zhang SQ; Yang Z; Cai XL; Zhao M; Sun MM; Li J; Feng GX; Feng JY; Ye LH; Niu JQ; Zhang XD
    Acta Pharmacol Sin; 2017 Aug; 38(8):1161-1170. PubMed ID: 28603285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR.
    Wang Y; Chen F; Zhao M; Yang Z; Zhang S; Ye L; Gao H; Zhang X
    Biochem Biophys Res Commun; 2016 Nov; 480(3):455-460. PubMed ID: 27773820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR.
    Wang Y; Cui M; Sun BD; Liu FB; Zhang XD; Ye LH
    Acta Pharmacol Sin; 2014 Sep; 35(9):1207-14. PubMed ID: 25087998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
    Zhang W; Lu Z; Gao Y; Ye L; Song T; Zhang X
    Biochem Biophys Res Commun; 2015 May; 460(3):793-8. PubMed ID: 25824049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-30e suppresses proliferation of hepatoma cells via targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) mRNA.
    Feng G; Shi H; Li J; Yang Z; Fang R; Ye L; Zhang W; Zhang X
    Biochem Biophys Res Commun; 2016 Apr; 472(3):516-22. PubMed ID: 26966067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.
    Liu F; You X; Chi X; Wang T; Ye L; Niu J; Zhang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):128-34. PubMed ID: 24434140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
    Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.
    Kong G; Zhang J; Zhang S; Shan C; Ye L; Zhang X
    PLoS One; 2011 May; 6(5):e19518. PubMed ID: 21573166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL.
    Cui X; Li Q; He Y
    Mol Cell Biochem; 2017 Jan; 424(1-2):195-201. PubMed ID: 27822662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.
    Li S; Li J; Fei BY; Shao D; Pan Y; Mo ZH; Sun BZ; Zhang D; Zheng X; Zhang M; Zhang XW; Chen L
    Chin Med J (Engl); 2015 Apr; 128(7):941-7. PubMed ID: 25836616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA.
    Lu Z; Zhang W; Gao S; Jiang Q; Xiao Z; Ye L; Zhang X
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):8-13. PubMed ID: 26549227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.
    Song L; Zhang W; Chang Z; Pan Y; Zong H; Fan Q; Wang L
    Med Sci Monit; 2017 Apr; 23():1741-1750. PubMed ID: 28394882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
    El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI
    FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4.
    Cui M; Xiao Z; Sun B; Wang Y; Zheng M; Ye L; Zhang X
    Biochem Biophys Res Commun; 2014 Mar; 445(3):651-5. PubMed ID: 24576478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells.
    Yan Y; Liang Z; Du Q; Yang M; Geller DA
    Oncol Rep; 2016 Aug; 36(2):633-40. PubMed ID: 27279136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.
    Yang Y; Li M; Chang S; Wang L; Song T; Gao L; Hu L; Li Z; Liu L; Yao J; Huang C
    Mol Med Rep; 2014 Nov; 10(5):2643-8. PubMed ID: 25174704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.
    Drakaki A; Hatziapostolou M; Polytarchou C; Vorvis C; Poultsides GA; Souglakos J; Georgoulias V; Iliopoulos D
    BMC Cancer; 2015 Jul; 15():542. PubMed ID: 26206264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.